Skip to main content
SpringerLink
Log in

Chemotherapeutic management of head and neck cancer

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

The use of chemotherapy in patients with head and neck cancer is increasing. In patients with recurrent head and neck cancer, a large number of chemotherapeutic drugs have shown antitumor activity. These drugs are discussed, and factors which influence response rate and survival are examined. New agents and treatment, including specific agents for combination chemotherapy, are presented.

There has been a search for new treatment or procedures in patients with previously untreated and locally advanced cancer of the head and neck. The results, including studies of combined modality therapy and chemotherapy after surgery, are discussed.

Chemotherapy in tumor of the salivary glands is briefly discussed, followed by an examination of intraarterial therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cachin Y, Eschwage F: Combination of radiotherapy and surgery in the treatment of head neck cancer. Cancer Treat Rev 2: 177–191, 1975

    Google Scholar 

  2. Fletcher GH, Jesse RH: The place of irradiation in the management of the primary lesion in head and neck cancer. Cancer 31: 862–867, 1977

    Google Scholar 

  3. Hintz B, Charyulu K, Chandler JR, Sudarsanam A, Garcia M: Randomized study of control of the primary tumor and survival using pre-operative radiation, radiation alone or surgery alone in head and neck carcinomas. J Surg Oncol 12: 75–85, 1979

    Google Scholar 

  4. Schuller DE, McGuirt WF, Krause CJ, McCabe BF, Pflung BK: Symposium: Adjuvant cancer therapy of head and neck tumors. Increased Survival with surgary alone vs. combined therapy. Laryngoscope 89: 582–594, 1979

    Google Scholar 

  5. Vandenbrouck C, Sancho H, LeFur R, Richard JM. Cachin Y: Results of a randomized clinical trial of preoperative irradiation vs. post-operative in treatment of tumors of the hypopharynx. Cancer 39: 1445–1449, 1977

    Google Scholar 

  6. Snow JB, Gelber RD, Kramer S, Davis LW, Marcial V, Lowry LD: Randomized pre-operative and post-operative radiation therapy for patients with carcinoma of the head and neck. Preliminary report. Laryngoscope 90: 930–945, 1980

    Google Scholar 

  7. Kramer S, Gelber RD, Snow JB, Davis LW, Marcial VA, Lowry LD: Peoperative vs. post-operative radiation therapy for patients with carcinoma of the head and neck. Progress report. Head and Neck Surg 3: 225, 1985

    Google Scholar 

  8. Vikram B, Strong EW, Shah JP, Spiro R: Failure at the primary site following multimodality treatment in advanced head and neck cancer. Head and Neck Surg 6: 720–723, 1984

    Google Scholar 

  9. Vikram B, Strong EW, Shah JP, Spiro R: Failure in the neck following multimodality treatment for advanced head and neck cancer. Head and Neck Surg 6: 724–729, 1984

    Google Scholar 

  10. Vikram B, Strong EW, Shah JP, Spiro R: Failure at distant sites following multimodality treatment for advanced head and neck cancer. Head and Neck Surg 6: 730–733, 1984

    Google Scholar 

  11. Probert JC, Thompson RW, Bagshaw MA: Patients of spread of distant metastases in head and neck cancer. Cancer 33: 127–133, 1974

    Google Scholar 

  12. O'Brien P, Carlson R, Steubner F, et al.: Distant metastases in epidermoid cell carcinoma of the head and neck. Cancer 27: 304–407, 1971

    Google Scholar 

  13. Papal JR: Distant metastases from head and neck cancer. Cancer 53: 342–345, 1984

    Google Scholar 

  14. Fazekos JT, Sommer C, Kramer S: Tumor regression and other prognosticators in advanced head and neck cancers. Int J Rad Oncol Biol Phys 9: 957–959, 1983

    Google Scholar 

  15. Al-Sarraf M: Chemotherapy strategies in squamous cell carcinoma of the head and neck. CRC Critical Rev in Oncol/Hematol 1: 323–355, 1984

    Google Scholar 

  16. Amer MH, Al-Sarraf,Vaitkevicius VK: Factors that effect response to chemotherapy and survival of patients with advanced head and neck cancer. Cancer 43: 2202–2206, 1979

    Google Scholar 

  17. Amer MH, Izbicki RM, Vaitkevicius VK, Al-Sarraf M: Combination chemotherapy with cis-diaminedichloro-platinum, oncovin and blcomycin (COB) in advanced head and neck cancer-phase II. Cancer 45: 217–223, 1980

    Google Scholar 

  18. Drelichman A, Cummings G, Al-Sarraf M: A randomized trial of the combination of cis-platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck. Cancer 52: 399–403, 1983

    Google Scholar 

  19. Kish JA, Weaver A, Jacobs J, et al.: Cis-platinum and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck. Cancer 53: 1819–1824, 1984

    Google Scholar 

  20. Kish JA, Ensley JF, Jacobs J, et al.: A randomized trial of cis-platinum (CACP) plus 5-fluorouracil (5-FU) infusion an CACP plus 5-FU bolus for recurrent and advanced squamous cell carcinomas of the head and neck. Cancer 56: 2740–2744, 1985

    Google Scholar 

  21. Jacobs C, Meyers F, Henderickson C, et al.: A randomized phase II study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California Oncology Group study. Cancer 52: 1563–1569, 1983

    Google Scholar 

  22. DeConti RC, Schoenfeld D: A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin and a methotrexate combination in head and neck cancer. Cancer 48: 1061–1072, 1981

    Google Scholar 

  23. Amrein PC, Weitzman SA: Treatment of squamous cell carcinoma of the head and neck with cisplatin and 5-fluorouracil. J Clin Oncol 3: 1632–1639, 1985

    Google Scholar 

  24. Eisenberger M, Hoth D, Posada J: New drug development in head and neck oncology. In: Wolf GT (ed) Head and Neck Oncology, Martinus Nijhoff Publishers, Boston, 1984, pp. 347–373

    Google Scholar 

  25. Al-Sarraf M, Drelichman A, Peppard S, Hoschner J, Kinzie J, Loh J, Weaver A: Adjuvant cis-platinum and 5-fluorouracil 96 hour infusion in previously untreated epidermoid cancers of the head and neck. Proc ASCO-AACR 22: 428, 1981

    Google Scholar 

  26. Rowland KM, Taylor IV SG, O'Donnell MR, Spiers A, Stho PB, Diconti RC, Milner L: Cisplatin/5-fluorouracil infusion chemotherapy in advanced recurrent cancer of the head and neck. An ECOG pilot study. Proc ASCO 3: 184, 1984

    Google Scholar 

  27. Creagan ET, Ingle JW, Schutt AJ, O'Fallon JR: A phase II study of cis-diamminedichloroplatinum and 5-fluorouracil in advanced upper aerodigestive neoplasms. Head and Neck Surg 6: 1020–1023, 1984

    Google Scholar 

  28. Sridher KS, Hirsch R, Fountzilas G, Goodwin VJ, Winson D, Broder LE: Sequential cisplatin (DDP) and 5-fluorouracil (5-FU) in advanced squamous cell head and neck cancer (H&N Ca). Proc AACR 25: 180, 1984

    Google Scholar 

  29. Dasmahapatra KS, Citrin P, Hill GJ, Yee R, Mirseyed A, Tabatabei M, Bush BF: A prospective evaluation of 5-fluorouracil plus cisplatin in advanced squamous cell cancer of the head and neck. J Clin Oncol 3: 1486–1489, 1985

    Google Scholar 

  30. Raymond MG, Lyman GH: Treatment of unresectable/recurrent epidermoid carcinoma of the head and neck (ECHN) with cisplatin plus 5-fluorouracil infusion. Proc ASCO 4: 133, 1985

    Google Scholar 

  31. Fossor VP, Paccagnella A, Venturelli E, et al.: Cisplatin (CDDP) + 5-fluorouracil (5-FU) 120 hour infusion in patients (Pts) with recurrent and disseminated head and neck cancer. Proc ASCO 4: 150, 1985

    Google Scholar 

  32. Al-Sarraf M: The cost clinical value of combination of cisplatinum, oncovin and bleomycin (COB) vs methotrexate in patients with advanced head and neck epidermoid cancer. (Abstract) Proc ASCO 21: 198, 1980

    Google Scholar 

  33. Holoye PY, Byers RM, Gard DA, Goepfert H, Illamondesui M, Jesse RH: Combination chemotherapy of head and neck cancer. Cancer 42: 1661–1669, 1978

    Google Scholar 

  34. Davis S, Kessler W: Randomized comparison of cis-platinum vs cis-platinum, bleomycin and methotrexate in recurrent squamous cell carcinoma of the head and neck. Cancer Chemother Pharmacol 3: 57–59, 1979

    Google Scholar 

  35. Browman GP, Archibald SD, Young JEM: Prospective randomized trial of one hour sequential versus simultaneous methotrexate plus 5-fluorouracil in advanced and recurrent squamous cell head and neck cancer. J Clin Oncol 1: 87–792, 1983

    Google Scholar 

  36. Hong WK, Schaefer S, Issell B, et al.: A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent squamous cell carcinoma of the head and neck. Cancer 52: 206–210, 1983

    Google Scholar 

  37. Taylor SG, McGuire WP, Hauck WW, Shoroel JL, Bhutani R, Analill A, Katz AE, Aner R, Wiffet R, Strong SM: A randomized comparison of high dose infusion methotrexate vorsus standard dose weekly therapy in head and neck squamous cancer. J Clin Oncol 2: 1006–1011, 1984

    Google Scholar 

  38. Gorse WE, Lehane DE, Dixon DO, Fletcher WS, Stuckey WJ: Comparison of methotrexate and cisplatin for patients with advanced squameus cell caroinona of the head and neck region: a Southwest Oncology Group study. Cancer Treat Rep 69: 577–581, 1985

    Google Scholar 

  39. Vogl SE, Schoenfeld DA, Kaplan BH, et al.: A randomized prospective comparison of methotrovate with a combination of methotrexate, bleomycin and eisplatin in head and neck cancer. Cancer 56: 432–442, 1985

    Google Scholar 

  40. Veronesi A, Zagonel V, Tirelli H, Gelligioni F, Tubnola S, Barman I, Lorenzini M, Comoretto R, Grigoletto F: High dose versus low dose eisplatin in advanced head and neck squamous carcinoma: a randomized study. J Clin Oncol 3: 1105–1108, 1985

    Google Scholar 

  41. Williams SD, Velez-Garcia E, Essessee I, et al.: Chemotherapy for head and neck cancer comparison of cisplatin + vinblastine-bleomycin versus methotrexate. Cancer 57: 18–23, 1986

    Google Scholar 

  42. Taylor IV SG: Head and neck cancer. In: Pinedo HM, Chabner BA (eds) Cancer Chemotherapy 7. Elsevier Science Publishers, 1985, pp. 287–301

  43. Hornudo-Muguiro J, So M, Spaulding MB, et al.: Phase II trial of carboplatin (CBDCA) in aero digestive malignansics. Proc ASCO 4: 136, 1986

    Google Scholar 

  44. Kish J, Ensley J, Al-Sarraf M, Vonhoff D, Schuller D: Activity of CHIP and CBDCA (platinum analogs) in recurrent epidermoid cancer of the head and neck (H&N). Proc ASCO 4: 130, 1985

    Google Scholar 

  45. Tarpley JL, Chretien PB, Alexander JC, Brik RP, Heenburg AG, Kirnis JM, Peslus GW: High dose methotrexate as a pre-operative adjuvant in the treatment of epidermoid carcinoma of the head and neck; a feasibility study and clinical trial. Am J Surg 130: 143–152, 1975

    Google Scholar 

  46. Hande KR, Chretien PB, Elias EB: Thirty-six hour pre-operative high dose methotrexate infusion in patients with squamous careinoma of the head and neck. Med Pediat One 6: 39–45, 1979

    Google Scholar 

  47. Gad-El-Mawla N, Abul-Ela M, Mansour MA. Mnedonald JS: Pre-operative adjuvant chemotherapy in relatively advanced head and neck cancer. Am J Clin Oncol (in press)

  48. Wittes R, Heller R, Randolph V, Howard J, Vallejo A, Farr H, Harrold C, Gerold F, Shah J, Spiro R, Strong E: Cis-dichlorodiammineplatinum (II) based chemotherapy as initial treatment of advanced head and neck cancer. Cancer Treat Rep 63: 1533–1538, 1979

    Google Scholar 

  49. Schaefer S, Middleton R, Carder H, Sudderth J, Graham M, Anderson R, Frenkel E: Efficacy of cis-platinum chemotherapy induction in multiple modality treatment of stanu IV squamous cell carcinoma of the head and neck. Proc AACR 22: 428, 1981

    Google Scholar 

  50. Glick JH, Marcial V, Richter M, Velez-Garcia E: The adjuvant treatment of inoperable stage III and IV epidermoid carcinoma of the head and neck with platinum and bleomycin infusion prior to definitive radiotherapy: a RTOG pilot study. Cancer 46: 1919–1024, 1980

    Google Scholar 

  51. Hong WK, Shapshay SM: Heatment of proviously untreated stage III and IV squamous cell careinoma of the head and neck. Otolaryng Clin North Am 13: 521–528, 1980

    Google Scholar 

  52. Pennacchio JL, Hong WK, Shapshay S, Gillis T, Vaughan C: Combination of eis-platinum and bleomycin prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced squamous cell carcinoma of the head and neck. Cancer 50: 2795–2801, 1982

    Google Scholar 

  53. Kloss R, Oster M, Blitzer A, et al.: Cis-platinum (P) and bleomycin (B) for previously untreated locally advanced squamous cell carcinoma of the head and neck Proc ASCO 22: 535, 1981

    Google Scholar 

  54. Randolph VL, Vallajo A, Spiro RH, Shah J, Strong EW, Huvos AS, Wittes RE: Combination therapy of advanced head and neck cancer: induction of remissions with dlamminedichloroplatinum (II), bleomycin and radiation therapy, Cancer 41: 460–467, 1978

    Google Scholar 

  55. Schmieder A, Jacobs H, Maurer H, Pfeifer H: Chemotheraple mit Cisplatin-Bleomycin und nachfolgende Strahlentherapie bei fortgeschrittenen Kopf-Hals-Tumoren. Klin Wochenschr 65: 35, 1984

    Google Scholar 

  56. Wolf GT, Jacobs C, Makuch RW, Vikram B: Cisplatin and bleomycin adjuvant chemotherapy in head and neck cancer: results of the head and neck contracts program. In: Vidockler HR (ed) Proceedings of the International Conference on Head and Neck Cancer. Lancaster Press, Baltimore, MD, 1984, p. 43

    Google Scholar 

  57. Isreal L, Aguilers J, Soudant J, Penot JC, Breau JL: Head and neck cancers, 57 patients treated with cis-platinum and continuous bleomycin: 53 patients treated with cis-platinum, mitomycin c and continuous bleomycin. Proc ASCO 1: 200, 1982

    Google Scholar 

  58. Coughlin CI, Grace M, O'Donnell JF, LeMarbre PJ, Morain WD, Geurkinle NA, McIntyre OR: Combined modality approach in the management of locally advanced head and neck cancer. Cancer Treat Rep 68: 591–597, 1984

    Google Scholar 

  59. Al-Sarraf M, Amer MH, Vaishampayon G, et al.: A multimodality therapeutic approach for advanced previously untreated epidermoid cancer of the head and neck: preliminary report. Int J Radiat Oncol Biol Phys 5: 1421–1423, 1979

    Google Scholar 

  60. Al-Sarraf M, Drelichman A, Jacobs J, et al.: Adjuvant chemotherapy with cisplatinum, oncovin, and bleomycin followed by surgery and/or radiotherapy in patients with advanced previously untreated head and neck cancer: final report. In: Jones SE, Salmon SE (eds) Adjuvant Therapy of Cancer III. Grune and Stratton, New York, 1981, pp 145–152

    Google Scholar 

  61. Amrein PC, Fingert H, Weitzman SA: Cisplatin, Vincristine, bleomycin therapy in squamous cell carcinoma of the head and neck. J Clin Oncol 1: 421–427, 1983

    Google Scholar 

  62. Brown AW, Blom J, Butler WM, Garcia-Guerrero G, Richardson MF, Henderson RL: Combination chemotherapy with vinblastine, bleomycin and cis-diammincdichloroplatinum (II) in squamous cell carcinoma of the head and neck. Cancer 45: 2830–2835, 1980

    Google Scholar 

  63. Spaulding M, Lore Jr JM, Klotch, Khan A: Introduction therapy in head and neck cancer: progress report. In: Vidockler HR (ed) Proceedings of the International Conference on Head and Neck Cancer, Lancaster Press, Baltimore, MD, 1984, p 44

    Google Scholar 

  64. Spaulding MB, Kahn A, De Los Santos R, Klotch D, Lore Jr JM: Adjuvant chemotherapy in advanced head and neck cancer: an update. Am J Surg 144: 432–436, 192

  65. Kukla LJ, Mantravade RVP, Applebaum EL, McGuire WP: Preirradiation chemotherapy for advanced head and neck carcinomas. Arch Otolaryngol 110: 78, 1984

    Google Scholar 

  66. Deneufbourg JM: Bleomycin, vepesid, platinol (BVP) chemotherapy before radical treatment in head and neck cancers. In: Vidocker HR (ed) Proceedings of the International Conference on Head and Neck Cancer. Lancaster Press, Baltimore, MD, 1984, p 48

    Google Scholar 

  67. Perry DJ, Davis RK, Weiss RB: Combined modality treatment with combination chemotherapy for advanced squamous cell carcinoma of the head and neck. Proc ASCO 1: 193, 1982

    Google Scholar 

  68. Mukhopadhyay P, Osman MR, Wajima T, Maxwell V, Alverson E, Subramanian VP, Kroening PM: Combined modality therapy for previously untreated advanced squamous cell carcinoma of the head and neck. Proc ASCO 4: 135, 1985

    Google Scholar 

  69. Elias EG, Chretian PB, Monnard E, Khan L, Bouchelle WH, Ubiernik PH, Lipson SD, Hande KR, Zentai T: Chemotherapy prior to local therapy in advanced squamous cell cancer of the head and neck: preliminary assessment of an intensive drug regimen. Cancer 43: 1025–1031, 1979

    Google Scholar 

  70. Ervin TJ, Weichselbaum R, Miller D: Treatment of advanced squamous cell carcinoma of the head and neck with cis-platinum, bleomycin and methotrexate (PBM). Cancer Treat Rep 65: 787–791, 1981

    Google Scholar 

  71. Ervin TJ, Weichselbaum RR, Fabian RL, Miller D, Norris Jr CM, Posner MR, Rose C, Lochhart P, Tuttle SA, MacIntyre JM, Frei E III: Advanced squamous carcinomas of the head and neck. A preliminary report of neoadjuvant chemotherapy in cisplatin, bleomycin and methotrexate. Arch Otolaryngol 110: 241, 1984

    Google Scholar 

  72. Kuten BH, Zidan J, Cohen Y, Robinson S: Multi-drug chemotherapy using bleomycin, methotrexate and cis-platinum alone or combined with radiotherapy in advanced head and neck cancer. Cancer Treat Rep 67: 573–574, 1983

    Google Scholar 

  73. Tannock I, Cummings B, Sorrenti V: ENT group. Combination chemotherapy prior to radiation therapy for locally advanced squamous cell carcinoma of the head and neck. Cancer Treat Rep 66: 1421–1424, 1982

    Google Scholar 

  74. Brun B, Mazeron JJ, Martin M, Lelievre G, Langlois A, Feuillade, Lebourgeois JP, Peynegre R, Grellet M, Pierquin B: Polychimiotherapie inital dans le traitement des cancers des voics acrodigestives superieurcs. Bull Cancer 71: 30, 1984

    Google Scholar 

  75. Kies MS, Pecaro BC, Gordon LI, Hauck WW, Kraut MJ, Krespi Y, Ossoff RH, Schiff C, Shetty R, Sisson GA: Preoperative combination chemotherapy for advanced stage head and neck cancer: promising early results. Am J Surg 148: 367, 1984

    Google Scholar 

  76. Adelstein DJ, Hines JD, Sharan VM, Earle AS, Haria CD, Shah AC, Vlastou C, Carter SG, Damm CJ: Chemotherapy with cis-platinum, bleomycin and methotrexate as initial management in advanced head and neck cancer. In: Vidockler HR (ed) Proceedings of the International Conference on Head and Neck Cancer. Lancester Press, Baltimore, MD., 1984, p 42

    Google Scholar 

  77. Rodrigucz V, Farrus B, Pera J, Manos GM, Pericot J, Riu R, Gomez P, Dicenta M, Escutia E, Juan A, Mexia M, Monner A, Salavert A, Piulachs P, Menen J, Manso PM, Segovia JL, deCaralt M: Integracion de la quimioterapia con la radiotherapia y cirgui en el tratamiento de los tumores avanzados de cabeza y cuello. Farm Clin 1: 32, 1984

    Google Scholar 

  78. Bruntsch U, Hiller T, Wandt H, Wolff L, Theissing J, Gallmeier WM: Primare chemotherapic fortgeschrittener plattenepithelkarzinome in Kopf-Hals-Bereich. Dcutsche Medizineische Wochenschrift 110: 1889, 1985

    Google Scholar 

  79. Boheim K, Spoendlin H: Three-year results of combined modality therapy in locally advanced, reseetable squamous cell carcinoma of the head and neck. Acta Oto-Laryngologica 100: 134, 1985

    Google Scholar 

  80. O'Donnell MR, Mohr RM, Baxter DH: Early recurrence following induction chemotherapy for stage IV head and neck cancers: rationale for additional therapy. J Surg Oncol 28: 207, 1985

    Google Scholar 

  81. Hupperets PSGJ, Van derVegt SGL, Bruaset I, Van denBroek P, Wagener DIT: Chemotherapy in advanced squamous cell carcinoma of the head and neck with methotrexate, bleomycin and cisplatin. Netherlands J Med 28: 352, 1985

    Google Scholar 

  82. Gill PG, Hains JD, Lyer P, Rozenbilds JG, Ahmad A, Abbott RL, David DJ, Ward GG, Brown MW, Harvey NDM: Chemotherapy of squamous cell cancer of the head and neck. Med J Aust 1: 463–466, 1983

    Google Scholar 

  83. Sridhar KS, Ohnuma T, Biller H, Holland JF, Ambinder EP, Barba J: Combination chemotherapy with high dose methotrexate, bleomycin and cisplatin in management of head and neck squamous cell carcinoma. Am J Clin Oncol 8: 55, 1985

    Google Scholar 

  84. Schuller DE, Wilson HE, Smith RE, Bately F, James AD: Pre-operative reductive chemotherapy for locally advanced carcinoma of the oral cavity, oropharynx and hypopharynx. Cancer 51: 15–19, 1983

    Google Scholar 

  85. Rozencweig M, Dodion P, Bruntsch U, Gallmeier W, Clavel M, Gignoux B, Funes HC, Cavalli F, Kirkpatrick A, Dalesio O, VanRimjenant M: Combination chemotherapy with cisplatin, methotrexate bleomycin and vincristine (CABO) in advanced squamous cell carcinoma of the head and neck. Cancer 54: 1499, 1984

    Google Scholar 

  86. Cognetti F, Pinnaro P, Carlini P, DelVecchio MR, Impiombato FA, Perrino A, Ruggeri EM, Cortese M: Combination chemotherapy (CABO) prior to radiation for locally advanced inoperable squamous cell carcinomas of the head and neck. J Exp Clin Cancer Res 3: 271, 1984

    Google Scholar 

  87. Schuller DE, Wilson H, Hodgson S, Mattox D: Preoperative reductive chemotherapy for stage III or IV operable epidermoid carcinoma of the oral cavity, oropharynx, hypopharynx or larynx, phase III, a Southwest Oncology Group study. In: Vidockler HR (ed) Proceedings of the International Conference on Head and Neck Cancer. Lancaster Press, Baltimore, MD, 1984, p 48

    Google Scholar 

  88. Al-Sarraf M, Kish J, Ensley J, Jacobs J, Kinzie J, Crissman J, Weaver A: Induction cisplatinum and 5-fluorouracil infusion before surgery and/or radiotherapy in patients with locally advanced head and cancer. Progress report. Proc AACR 25: 196, 1984

    Google Scholar 

  89. Kies MS, Lester EP, Johnson CM, Blough RR, Gongol J, Krespi Y, Ossoff RH, Pecaroo BC, Taylor SGIV, Sisson GA: Cisplatin and infusion 5-fluorouracil (5-FU) in stage III and IV squamous cancer of the head and neck. In: Vidockler HR (ed) Proceedings of the International Conference on Head and Neck Cancer. Lancaster Press, Baltimore, MD, 1984, p 43

    Google Scholar 

  90. Kies MS, Lester EP, Gordon LI, Blough RR, Gongol J, Taylor SGIV: Cis-platin and infusion 5-fluorouracil in stage III and IV squamous cancer of the head and neck. Proc ASCO 4: 139, 1985

    Google Scholar 

  91. Joveniaux A, Caty A, Adenis L: L'association de cislatine ct de 5 fluoro-uracil dans le traitement primaire des carcinomes evolues des voies acro-digestive supcrieures. Bull Cancer 71: 390, 1984

    Google Scholar 

  92. Soherpe A, Schroder M, vonHeyden HW, Nagel GA: Chemotherapieergebnisse mit cisplatin and 5-fluorouracil bei plattenepithelkarzinomen des kopf-hals-bereiches. Onkologie 7: 302, 1984

    Google Scholar 

  93. Al-Sarraf M, Pajak T, Iaramore G: Timing of chemotherapy as part of definitive treatment for patients with advanced head and neck cancer. An RTOB study. Proc ASCO 4: 137, 1985

    Google Scholar 

  94. Jacobs C, Goffinet D, Fee W, Goffinet L, Hopp M: Chemotherapy as a substitute in the treatment of advanced operable head and neck cancer: an NCOG pilot. Proc ASCO 4: 137, 1985

    Google Scholar 

  95. Gordon RA, O'Brien E, Lipton A, Harvey HA, Simmands M, Strauss M, Hauck J: Combined modality therapy of locally advanced stage IV squamous cell carcinoma of the head and neck. Proc ASCO 4: 135, 1985

    Google Scholar 

  96. Haas C, Byhardt R, Cox J, Duncovage J, Grossman T, Haas JC, Hartz A, Libnoch J, Malin T, Ritch P, Toohill R: Randomized study of 5-fluorouracil (F) and cis-platinum (P) as initial therapy of locally advanced squamous carcinoma of the head and neck (LASCHN): a preliminary analysis. Proc ASCO 4: 143, 1985

    Google Scholar 

  97. Greenberg B, Ahmann F, Garewal H, Koopmann C, Coulthard S, Berzes H, Alberts D: Neoadjuvant therapy for advanced head and neck cancer with allopurinol-modulated high dose 5-fluorouracil (5-FU) and cis-platinum (CP). Proc ASCO 4: 146, 1985

    Google Scholar 

  98. Laccourreve H, Bassot V, Lacau Saint Guily J, Brasnu D, Menard M, Donnadieu S, Jacquillat CI: Chimiotherapue d'induction dans les cancers des voies acro-digestives superieures. Resultats preliminaires du protocole cisplatyl, 5 fluorouracile, bleomycine (CFB). Annals of Oto-Laryngol (Paris) 102: 1, 1985

    Google Scholar 

  99. Milazzo J, Mohit-Tabatabai MA, Hill GJ, Raina S, Swaminathan A, Cheung NK, Dasmahapatra K, Rush Jr BG: Preoperative intra-arterial infusion chemotherapy for advanced squamous cell carcinoma of the mouth and oropharynx. Cancer 56: 104, 1985

    Google Scholar 

  100. Gonzalez MF, Valdivieso JG, Sartiano GP: Continuous intravenous infusion combination chemotherapy for head and neck squamous cell carcinoma. Oncology 41: 377, 1984

    Google Scholar 

  101. Vogl SE, Lerner H, Kaplan BM, Coughlin C, McCormick B, Camacho F, Cinsberg J: Failure of effective initial chemotherapy to modify the course of stage IV (Mo) squamous cancer of the head and neck. Cancer 50: 840–847, 1982

    Google Scholar 

  102. Spaulding MB, Vasquez J, Khan A, Sundquist N, Lore JM: A nontoxic adjuvant treatment for advanced head and neck cancer. Arch Otolaryngol 109: 789, 1983

    Google Scholar 

  103. Focan C, Salamon E, LeHung S, Frere MH, Mbuyamba P, Claessens JJ: Efficacite d'une chimiotherapic sequenticlle incluant la vincristine, le cis platine et l'ifosfamide dans le staitement des carcinomas de la tete et du cou stade IV et des melanomes a vec atteinte visceral. Bull Cancer 71: 105, 1984

    Google Scholar 

  104. Krasnow SH, Cohen MH, Johnston-Early A, Citron ML, Fossieck BE Jr, Mauk CM, Yenson A, Banda FP, Lunzar S, deFries HO: Combined therapy for stage III and IV head and neck cancer. Preliminary results. J Clin Oncol 2: 804–810, 1984

    Google Scholar 

  105. Feldman J, Ellingwood K, Clarkson D: Up front bleo-cap chemotherapy produces a 100% response rate (33% complete response) in previously untreated advanced head and neck cancer. Proc ASCO 1: 193, 1982

    Google Scholar 

  106. Al-Kourainy K, Crissman J, Ensley J, Kish J, Simpson W, Dummings G, Al-Sarraf M: Achievement of superior survival of histologically negative vs. histologically positive clinically complete responders to cis-platinum (CACP) combinations in patients with locally advanced head and neck cancer. Proc AACR 26: 164, 1985

    Google Scholar 

  107. Schwert R, Jacobs JR, Crissman J, Kinzie J, Weaver A, Vaitkevicius VK, Al-Sarraf M: Improved survival in patients with advanced head and neck cancer achieving complete clinical response to induction chemotherapy. Proc ASCO 2: 159, 1983

    Google Scholar 

  108. Weaver A, Flemings S, Ensley J, Kish JA, Jacobs J, Kinzie J, Crissman J, Al-Sarraf M: Superior complete clinical response and survival rates with initial bolus cisplatinum and 120 hour 5-fluorouracil infusion before definitive therapy in patients with locally advanced head and neck cancer. Am J Surg 148: 525–529, 1984

    Google Scholar 

  109. Rooney M, Stanley R, Weaver A, Crissman J, Vinzie J, Sexon-Porte M, Al-Sarraf M: Superior results in complete response rate and overall survival in patients with advanced head and neck cancer treated with three courses of 120 hour 5-FU infusion and cis-platinum. Proc ASCO 2: 159, 1983

    Google Scholar 

  110. Rooney M, Kish J, Jacobs J, et al.: Improved complete response rate and survival in advanced head and neck cancer after 3 course induction therapy with 120 hour 5-FU infusion and cis-platinum. Cancer 55: 1123–1128, 1985

    Google Scholar 

  111. Al-Sarraf M, Kinzie J, Jacobs J, Loh JJR, Weaver A: New way of giving chemotherapy as part of multi-disciplinary treatment for patients with head and neck cancers. Preliminary report. Proc AACR 23: 134, 1982

    Google Scholar 

  112. Jacobs C: The use of chemotherapy in combination with radiotherapy in the treatment of head and neck squamous cancers. In: Wolf GT (ed) Head and Neck Oncology, Martinus Nijhoff Publishers, Boston, 1984, pp 265–286

    Google Scholar 

  113. Al-Sarraf M, Jacobs J, Kinzie J, Marcial V, Velez-Garcia E, Glick J, Fu K: Combined modality therapy utilizing single high intermittent dose of cis-platinum and radiation in patients with advanced head and neck cancer. Proc ASCO 2: 159, 1983

    Google Scholar 

  114. Al-Sarraf M, Marcial V, Mowry P, Green M, Laramore G, Pajak T: Superior local control with combination of high dose cis-platinum and radiotherapy. An RTOG study. Proc AACR 26: 169, 1985

    Google Scholar 

  115. Donegan WL, Harris HS: Factors influencing the success of arterial infusion chemotherapy for cancer of the head and neck. Am J Surg 123: 549–559, 1972

    Google Scholar 

  116. Freckman HA: Results in 169 patients with cancer of the head and neck treated by intra-arterial infusion therapy. Am J Surg 124: 501–509, 1972

    Google Scholar 

  117. Huntington C, DuPriest RW, Fletcher WS: Intra-arterial bleomycin therapy in inoperable squamous cell carcinomas. Cancer 31: 153–158, 1973

    Google Scholar 

  118. Donegan WL, Harris P: Regional chemotherapy with combined drugs in cancer of the head and neck. Cancer 38: 1479–1483, 1976

    Google Scholar 

  119. Baker SR, Ensminger WD, Niederhuber JE: Intra-arterial infusion chemotherapy for head and neck cancer using a totally implantable infusion pump. Head and Neck Surg 4: 118–124, 1981

    Google Scholar 

  120. Mika H: Remission rates of advanced squamous cell carcinoma of the oral cavity and oropharynx after intra-arterial poly-chemotherapy with vincristine, methotrexate, bleomycin and cisplatin (VMBP). Laryngol Rhinol Otol 61: 520–523, 1983

    Google Scholar 

  121. Baker SE, Wheeler R: Intra-arterial infusion chemotherapy of head and neck cancer. In: Wolf GT (ed) Head and Neck Oncology, Martinus Nijhoff Publishers, Boston, pp 302–345, 1984

    Google Scholar 

  122. Fu KK, Leibel SA, Levine ML, Friedlander LM, Boles R, Phillips TL: Cancer of the major and minor salivary glands: analysis of pretreatment results and sites and causes of failure. Cancer 40: 2882–2890, 1977

    Google Scholar 

  123. Suen JY, Johnson ME: Chemotherapy for salivary gland cancer. Laryngoscope 92: 235–239, 1982

    Google Scholar 

  124. Posner MR, Ervin TJ, Weichselbaum RR, et al.: Chemotherapy for advanced salivary gland neoplasm. Cancer 50: 2261–2264, 1982

    Google Scholar 

  125. Alberts DS, Manning MR, Coulthard SM, Roopmann R, Herman TS: Adriamycin/cis-platinum/cyclophosphamide combination chemotherapy for advanced carcinoma of the parotid gland. Cancer 47: 645–648, 1981

    Google Scholar 

  126. Tannock IF, Southerland DJ: Chemotherapy for adenoid cystic carcinoma. Cancer 46: 452–454, 1980

    Google Scholar 

  127. Schramm Jr VL, Srodes C, Myers EH: Cisplatin therapy for adenoid cystic carcinoma. Arch Otolaryngol 107: 738–741, 1981

    Google Scholar 

  128. Budd GT, Groppa CW: Adenoid cystic carcinoma of the salivary gland: sustained complete response to chemotherapy. Cancer 51: 589–590, 1983

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Oncology, School of Medicine, Wayne State University/Harper Grace Hospitals, 48201, Detroit, Michigan, USA

    Muhyi Al-Sarraf

Authors
  1. Muhyi Al-Sarraf
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Al-Sarraf, M. Chemotherapeutic management of head and neck cancer. Cancer Metast Rev 6, 181–198 (1987). https://doi.org/10.1007/BF00144263

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00144263

Key words

Search

Navigation